Combination of 5-FU with ChoKα inhibitors as a new alternative therapy in colorectal cancer

被引：0
|
作者：
de la Cueva, Ana [1 ]
Ramirez de Molina, Ana [2 ]
Angeles Ramos, Ma [1 ]
Cebrian, Aranzazu [1 ]
Gomez del Pulgar, Teresa [1 ]
Carlos Lacal, Juan [1 ]
机构：
[1] Inst Invest Biomed Madrid, Madrid, Spain
[2] IMDEA Food Inst, Madrid, Spain
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    CANCER, 1972, 29 (05) : 1308 - +
  • [32] Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
    Gamelin, EC
    DanquechinDorval, EM
    Dumesnil, YF
    Maillart, PJ
    Goudier, MJ
    Burtin, PC
    Delva, RG
    Lortholary, AH
    Gesta, PH
    Larra, FG
    CANCER, 1996, 77 (03) : 441 - 451
  • [33] A phase II trial of gefitinib in combination with 5-FU/LV/irinotecan in patients with colorectal cancer.
    Redlinger, M
    Kramer, A
    Flaherty, K
    Sun, W
    Haller, D
    O'Dwyer, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 310S - 310S
  • [34] Effects of Carbon Ion Beam Alone or in Combination with 5-FU on Colorectal Cancer Stem Cells In Vitro
    Koom, Woong Sub
    Sai, Sei
    Takizawa, Kazuya
    Suzuki, Masao
    Fujimori, Akira
    Yamada, Shigeru
    Kamada, Tadashi
    Tsujii, Hirohiko
    CANCER SCIENCE, 2018, 109 : 1311 - 1311
  • [35] SEQUENTIAL METHOTREXATE AND 5-FU IN CMFP (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FU, AND PREDNISONE) THERAPY FOR BREAST-CANCER
    CADMAN, EC
    GLICK, JH
    CROSS, J
    HORTON, J
    TAYLOR, SG
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 877 - 879
  • [36] HSPC1 INHIBITORS POTENTIATE THE EFFECT OF 5-FU IN PRIMARY COLORECTAL CANCER CELL MODEL
    Lee, S. L.
    Dempsey-Hibbert, N. C.
    Sutton, P.
    Vimalachandran, D.
    Wardle, T. D.
    Williams, J.
    GUT, 2014, 63 : A129 - A129
  • [37] 5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer
    Blaschke, Martina
    Cameron, Silke
    Goeschen, Colin
    Ramadori, Giuliano
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 56 - 58
  • [38] 5-FU VERSUS COMBINATION THERAPY WITH TUBERCIDIN, STREPTOZOTOCIN, AND 5-FU IN THE TREATMENT OF PANCREATIC CARCINOMAS - COG PROTOCOL-7230
    AWRICH, A
    FLETCHER, WS
    KLOTZ, JH
    MINTON, JP
    HILL, GJ
    AUST, JB
    GRAGE, TB
    MULTHAUF, PM
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (03) : 267 - 273
  • [39] PHASE-I TRIAL OF COMBINATION THERAPY WITH PALA AND 5-FU
    MESHAD, MW
    ERVIN, TJ
    KUFE, D
    JOHNSON, RK
    BLUM, RH
    FREI, E
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 331 - 334
  • [40] CAN UFT REPLACE INFUSIONAL 5-FU IN COMBINATION THERAPY FOR METASTATIC COLORECTAL CANCER (MCRC)? PRELIMINARY RESULTS OF THE RANDOMISED "FUTURE'' STUDY
    Douillard, J.
    Rolski, J.
    Barone, C.
    Schaberl-Moser, R.
    Eggleton, S. P.
    ANNALS OF ONCOLOGY, 2008, 19 : 134 - 134
12345